Key result
Perioperative anticoagulant management requires balancing the patient's risk of a thromboembolic event when warfarin is interrupted against the risk of bleeding associated with the procedure.
Why the study?
How should perioperative anticoagulant management be approached in patients requiring temporary interruption of warfarin therapy for elective surgery or invasive procedures?
How should perioperative anticoagulant management be approached in patients requiring temporary interruption of warfarin therapy for elective surgery or invasive procedures?
This review provides a practical approach for managing perioperative anticoagulation in patients requiring temporary interruption of warfarin therapy.
Answers are grounded in this paper and cite their sources.
Risk stratification guides individualized perioperative warfarin decisions; leaves open optimal bridging strategies pending higher-level evidence.
The management of patients who require temporary interruption of warfarin therapy because of elective surgery or another invasive procedures is clinically important because of the increasing prevalence of patients who are receiving warfarin and the availability of low-molecular-weight heparins, which facilitate out-of-hospital perioperative anticoagulation. The two main issues that need to be considered in perioperative anticoagulant management is the patient's risk of a thromboembolic event when warfarin therapy is interrupted and the risk of bleeding that is associated with the surgery or procedure. An assessment of these factors will determine the optimal perioperative anticoagulant management approach. The overall objective of this review is to provide a practical approach relating to perioperative anticoagulation which can be used in everyday clinical practice.
No takes yet. Share an insight, caveat, or question.
Douketis et al. (2008) conducted a review in Patients requiring temporary interruption of warfarin therapy for elective surgery or invasive procedures. Perioperative anticoagulant management was evaluated. Perioperative anticoagulant management requires balancing the patient's risk of a thromboembolic event when warfarin is interrupted against the risk of bleeding associated with the procedure.
Synapse has enriched 10 related papers. Consider them for comparative context: